Free Trial
NASDAQ:PNTG

The Pennant Group (PNTG) Stock Price, News & Analysis

The Pennant Group logo
$25.39 +0.16 (+0.63%)
As of 12:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About The Pennant Group Stock (NASDAQ:PNTG)

Key Stats

Today's Range
$25.05
$25.46
50-Day Range
$25.23
$30.22
52-Week Range
$21.18
$37.13
Volume
32,640 shs
Average Volume
215,895 shs
Market Capitalization
$875.19 million
P/E Ratio
33.41
Dividend Yield
N/A
Price Target
$34.60
Consensus Rating
Moderate Buy

Company Overview

The Pennant Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

PNTG MarketRank™: 

The Pennant Group scored higher than 68% of companies evaluated by MarketBeat, and ranked 340th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    The Pennant Group has only been the subject of 3 research reports in the past 90 days.

  • Read more about The Pennant Group's stock forecast and price target.
  • Earnings Growth

    Earnings for The Pennant Group are expected to grow by 17.33% in the coming year, from $0.75 to $0.88 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of The Pennant Group is 33.22, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.21.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of The Pennant Group is 33.22, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.20.

  • Price to Earnings Growth Ratio

    The Pennant Group has a PEG Ratio of 2.14. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    The Pennant Group has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about The Pennant Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.15% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently increased by 13.76%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    The Pennant Group does not currently pay a dividend.

  • Dividend Growth

    The Pennant Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.15% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently increased by 13.76%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    The Pennant Group has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for The Pennant Group this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for PNTG on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, The Pennant Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $164,387.00 in company stock.

  • Percentage Held by Insiders

    Only 5.40% of the stock of The Pennant Group is held by insiders.

  • Percentage Held by Institutions

    85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about The Pennant Group's insider trading history.
Receive PNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Pennant Group and its competitors with MarketBeat's FREE daily newsletter.

PNTG Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Pennant Group appoints new board director
See More Headlines

PNTG Stock Analysis - Frequently Asked Questions

The Pennant Group's stock was trading at $26.52 at the beginning of 2025. Since then, PNTG stock has decreased by 4.3% and is now trading at $25.3690.

The Pennant Group, Inc. (NASDAQ:PNTG) posted its earnings results on Wednesday, February, 28th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.01. The business earned $145.95 million during the quarter, compared to analysts' expectations of $136.79 million. The Pennant Group had a net margin of 3.40% and a trailing twelve-month return on equity of 10.73%.
Read the conference call transcript
.

Top institutional shareholders of The Pennant Group include Kings Path Partners LLC (0.05%). Insiders that own company stock include John G Nackel, Brent Guerisoli, John J Gochnour, Jennifer Freeman and Joanne Stringfield.
View institutional ownership trends
.

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that The Pennant Group investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ServiceNow (NOW), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
2/28/2024
Today
7/14/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PNTG
CIK
1766400
Fax
N/A
Employees
7,000
Year Founded
N/A

Price Target and Rating

High Price Target
$38.00
Low Price Target
$31.00
Potential Upside/Downside
+37.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.76
Trailing P/E Ratio
33.20
Forward P/E Ratio
33.64
P/E Growth
2.14
Net Income
$22.56 million
Net Margins
3.40%
Pretax Margin
4.80%
Return on Equity
10.73%
Return on Assets
4.00%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
1.41
Quick Ratio
1.41

Sales & Book Value

Annual Sales
$695.24 million
Price / Sales
1.25
Cash Flow
$0.92 per share
Price / Cash Flow
27.36
Book Value
$9.08 per share
Price / Book
2.78

Miscellaneous

Outstanding Shares
34,470,000
Free Float
32,608,000
Market Cap
$869.68 million
Optionable
Optionable
Beta
1.51
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PNTG) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners